← Browse by Condition
Medical Condition

egfr gene mutation

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT06643000
Recruiting

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

Enrollment
60 pts
Location
China
Sponsor
Henan Cancer Hospital
View Trial →
NCT06716580
Recruiting

EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations

Enrollment
1,000 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT04322890 Phase 2
Recruiting

Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation

Enrollment
6,000 pts
Location
China
Sponsor
Hunan Province Tumor Hospital
View Trial →